- a programming editor;
- faster simulation speed with major simulators;
- expanded mismatch and variation modeling solutions; and
- a streamlined and flexible user interface to create, manage, monitor, and debug measurement test plans.
What's next for shares of Agilent Technology.
Agilent turned in another stellar earnings results.
Previously studies already showed improvement from use of Exelixis's Cabometyx over Pfizer's Sutent in treating kidney cancer patients.
U.S. stock futures are higher on Tuesday.